Amphastar Pharmaceuticals, Inc. (AMPH) free cash flow

Free cash flow · fiscal 2025
$118.98M

Amphastar Pharmaceuticals, Inc. (AMPH) generated free cash flow of $118.98M in fiscal 2025 (the year ended December 31, 2025). That is 31.0% lower than the $172.35M of fiscal 2024. Figures as of 18 Nov 2026, 12:56 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$118.98M
Change on fiscal 2024
−31.0%
Growth, 5 years
+38.4% a year
Highest on record
$172.35Mfiscal 2024
Lowest on record
-$24.78Mfiscal 2012
Fiscal years on record
142012–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Amphastar Pharmaceuticals, Inc. free cash flow, in more detail

Over the five fiscal years to 2025 free cash flow grew at a compound 38.4% a year. Across the 14 fiscal years on record (2012–2025), the highest was $172.35M in fiscal 2024 and the lowest -$24.78M in fiscal 2012.

History · 14 fiscal years

Free cash flow by fiscal year

Amphastar Pharmaceuticals, Inc. free cash flow, year by year

Amphastar Pharmaceuticals, Inc. (AMPH) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$118.98M 31.0% down
2024$172.35M 18.6% up
2023$145.34M 123.1% up
2022$65.15M 7.6% down
2021$70.54M 201.3% up
2020$23.41M 11,209.7% up
2019$207.00K—
2018-$8.62M 309.7% down
2017$4.11M 76.1% down
2016$17.18M—
2015-$5.32M 1,061.1% down
2014$553.00K 95.9% down
2013$13.40M—
2012-$24.78M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

More on AMPH

Amphastar Pharmaceuticals, Inc., figure by figure

Amphastar Pharmaceuticals, Inc. (AMPH) overview: price, valuation and scorecard

Amphastar Pharmaceuticals, Inc. free cash flow: questions and answers

What is Amphastar Pharmaceuticals, Inc.'s free cash flow?

Amphastar Pharmaceuticals, Inc. (AMPH) generated free cash flow of $118.98M in fiscal 2025 (the year ended December 31, 2025). That is 31.0% lower than the $172.35M of fiscal 2024.

What is the growth rate of Amphastar Pharmaceuticals, Inc.'s free cash flow?

Over the five fiscal years to 2025 free cash flow grew at a compound 38.4% a year.

What are the highest and lowest free cash flow figures on record for Amphastar Pharmaceuticals, Inc.?

Across the 14 fiscal years on record (2012–2025), the highest was $172.35M in fiscal 2024 and the lowest -$24.78M in fiscal 2012.

How is Amphastar Pharmaceuticals, Inc.'s free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Amphastar Pharmaceuticals, Inc. it is on record here for 14 fiscal years, 2012 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Amphastar Pharmaceuticals, Inc. (AMPH) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/AMPH/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.